Sanara MedTech (SMTI) Stock Forecast, Price Target & Predictions
SMTI Stock Forecast
Sanara MedTech stock forecast is as follows: an average price target of $44.00 (represents a 22.22% upside from SMTI’s last price of $36.00) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
SMTI Price Target
The average price target for Sanara MedTech (SMTI) is $44.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $44.00 to $44.00. This represents a potential 22.22% upside from SMTI's last price of $36.00.
SMTI Analyst Ratings
According to 1 Wall Street analysts, Sanara MedTech's rating consensus is 'Buy'. The analyst rating breakdown for SMTI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sanara MedTech Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 26, 2024 | Ross Osborn | Cantor Fitzgerald | $44.00 | $36.75 | 19.73% | 22.22% |
The latest Sanara MedTech stock forecast, released on Mar 26, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $44.00, which represents a 19.73% increase from the stock price at the time of the forecast ($36.75), and a 22.22% increase from SMTI last price ($36.00).
Sanara MedTech Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $44.00 |
| Last Closing Price | $36.00 | $36.00 | $36.00 |
| Upside/Downside | -100.00% | -100.00% | 22.22% |
In the current month, the average price target of Sanara MedTech stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sanara MedTech's last price of $36.00. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Mar 26, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Sanara MedTech's last stock rating was published by Cantor Fitzgerald on Mar 26, 2024. The company gave SMTI a "Overweight" rating, the same as its previous rate.
Sanara MedTech Financial Forecast
Sanara MedTech Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $17.69M | $16.02M | $15.75M | $15.52M | $15.32M | $13.04M | $9.67M | $7.03M | $5.82M | $6.28M |
| Avg Forecast | $26.50M | $25.40M | $24.00M | $23.20M | $22.40M | $20.70M | $19.10M | $18.50M | $15.39M | $18.80M | $16.90M | $16.20M | $14.80M | $14.70M | $8.70M | $6.10M | $6.30M | $5.80M |
| High Forecast | $26.50M | $25.40M | $24.00M | $23.20M | $22.40M | $21.30M | $19.10M | $18.50M | $15.39M | $18.80M | $16.90M | $16.20M | $14.80M | $14.70M | $8.70M | $6.10M | $6.30M | $5.80M |
| Low Forecast | $26.50M | $25.40M | $24.00M | $23.20M | $22.40M | $20.10M | $19.10M | $18.50M | $15.39M | $18.80M | $16.90M | $16.20M | $14.80M | $14.70M | $8.70M | $6.10M | $6.30M | $5.80M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 1.15% | 0.85% | 0.93% | 0.96% | 1.03% | 0.89% | 1.11% | 1.15% | 0.92% | 1.08% |
Sanara MedTech's average Quarter revenue forecast for Mar 24 based on 1 analysts is $18.50M, with a low forecast of $18.50M, and a high forecast of $18.50M. SMTI's average Quarter revenue forecast represents a 4.58% increase compared to the company's last Quarter revenue of $17.69M (Dec 23).
Sanara MedTech EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $168.26K | $-590.73K | $-1.42M | $-890.13K | $-3.24M | $-2.18M | $-2.78M | $-3.36M | $-1.84M | $-1.11M |
| Avg Forecast | $-5.52M | $-5.29M | $-5.00M | $-4.84M | $-4.67M | $-4.31M | $-3.98M | $-3.86M | $-3.21M | $-3.92M | $-3.52M | $-3.38M | $-3.08M | $-3.25M | $-1.92M | $-1.35M | $-1.39M | $-1.28M |
| High Forecast | $-5.52M | $-5.29M | $-5.00M | $-4.84M | $-4.67M | $-4.19M | $-3.98M | $-3.86M | $-3.21M | $-3.92M | $-3.52M | $-3.38M | $-3.08M | $-3.25M | $-1.92M | $-1.35M | $-1.39M | $-1.28M |
| Low Forecast | $-5.52M | $-5.29M | $-5.00M | $-4.84M | $-4.67M | $-4.44M | $-3.98M | $-3.86M | $-3.21M | $-3.92M | $-3.52M | $-3.38M | $-3.08M | $-3.25M | $-1.92M | $-1.35M | $-1.39M | $-1.28M |
| Surprise % | - | - | - | - | - | - | - | - | -0.05% | 0.15% | 0.40% | 0.26% | 1.05% | 0.67% | 1.45% | 2.49% | 1.32% | 0.86% |
1 analysts predict SMTI's average Quarter EBITDA for Mar 24 to be $-3.86M, with a high of $-3.86M and a low of $-3.86M. This is -2391.51% lower than Sanara MedTech's previous annual EBITDA (Dec 23) of $168.26K.
Sanara MedTech Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $89.01K | $-1.06M | $-1.83M | $-1.50M | $-11.71M | $-1.53M | $-3.25M | $-3.55M | $-2.02M | $-1.17M |
| Avg Forecast | $-1.87M | $-1.96M | $-2.73M | $-2.90M | $-3.32M | $-5.28M | $-1.79M | $-596.22K | $-1.11M | $11.82M | $-1.11M | $-2.81M | $-2.21M | $-2.71M | $-2.37M | $-2.29M | $-1.52M | $-1.02M |
| High Forecast | $-1.87M | $-1.96M | $-2.73M | $-2.90M | $-3.32M | $-5.28M | $-1.79M | $-596.22K | $-1.11M | $11.82M | $-1.11M | $-2.81M | $-2.21M | $-2.71M | $-2.37M | $-2.29M | $-1.52M | $-1.02M |
| Low Forecast | $-1.87M | $-1.96M | $-2.73M | $-2.90M | $-3.32M | $-5.28M | $-1.79M | $-596.22K | $-1.11M | $11.82M | $-1.11M | $-2.81M | $-2.21M | $-2.71M | $-2.37M | $-2.29M | $-1.52M | $-1.02M |
| Surprise % | - | - | - | - | - | - | - | - | -0.08% | -0.09% | 1.65% | 0.54% | 5.29% | 0.56% | 1.37% | 1.55% | 1.33% | 1.15% |
Sanara MedTech's average Quarter net income forecast for Mar 24 is $-596.22K, with a range of $-596.22K to $-596.22K. SMTI's average Quarter net income forecast represents a -769.86% decrease compared to the company's last Quarter net income of $89.01K (Dec 23).
Sanara MedTech SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $16.34M | $13.88M | $13.81M | $12.97M | $14.11M | $12.06M | $10.43M | $9.16M | $6.92M | $6.56M |
| Avg Forecast | $28.36M | $27.18M | $25.68M | $24.83M | $23.97M | $22.15M | $20.44M | $19.80M | $16.47M | $20.12M | $18.09M | $17.34M | $15.84M | $15.73M | $9.31M | $6.53M | $6.74M | $6.21M |
| High Forecast | $28.36M | $27.18M | $25.68M | $24.83M | $23.97M | $22.80M | $20.44M | $19.80M | $16.47M | $20.12M | $18.09M | $17.34M | $15.84M | $15.73M | $9.31M | $6.53M | $6.74M | $6.21M |
| Low Forecast | $28.36M | $27.18M | $25.68M | $24.83M | $23.97M | $21.51M | $20.44M | $19.80M | $16.47M | $20.12M | $18.09M | $17.34M | $15.84M | $15.73M | $9.31M | $6.53M | $6.74M | $6.21M |
| Surprise % | - | - | - | - | - | - | - | - | 0.99% | 0.69% | 0.76% | 0.75% | 0.89% | 0.77% | 1.12% | 1.40% | 1.03% | 1.06% |
Sanara MedTech's average Quarter SG&A projection for Mar 24 is $19.80M, based on 1 Wall Street analysts, with a range of $19.80M to $19.80M. The forecast indicates a 21.19% rise compared to SMTI last annual SG&A of $16.34M (Dec 23).
Sanara MedTech EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $0.01 | $-0.13 | $-0.22 | $-0.18 | $-1.48 | $-0.19 | $-0.42 | $-0.47 | $-0.27 | $-0.16 |
| Avg Forecast | $-0.22 | $-0.23 | $-0.32 | $-0.34 | $-0.39 | $-0.62 | $-0.21 | $-0.07 | $-0.13 | $1.39 | $-0.13 | $-0.33 | $-0.26 | $-0.32 | $-0.28 | $-0.27 | $-0.18 | $-0.12 |
| High Forecast | $-0.22 | $-0.23 | $-0.32 | $-0.34 | $-0.39 | $-0.62 | $-0.21 | $-0.07 | $-0.13 | $1.39 | $-0.13 | $-0.33 | $-0.26 | $-0.32 | $-0.28 | $-0.27 | $-0.18 | $-0.12 |
| Low Forecast | $-0.22 | $-0.23 | $-0.32 | $-0.34 | $-0.39 | $-0.62 | $-0.21 | $-0.07 | $-0.13 | $1.39 | $-0.13 | $-0.33 | $-0.26 | $-0.32 | $-0.28 | $-0.27 | $-0.18 | $-0.12 |
| Surprise % | - | - | - | - | - | - | - | - | -0.08% | -0.09% | 1.69% | 0.55% | 5.69% | 0.59% | 1.50% | 1.74% | 1.50% | 1.33% |
According to 1 Wall Street analysts, Sanara MedTech's projected average Quarter EPS for Mar 24 is $-0.07, with a low estimate of $-0.07 and a high estimate of $-0.07. This represents a -748.15% decrease compared to SMTI previous annual EPS of $0.01 (Dec 23).
Sanara MedTech Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ANGO | AngioDynamics | $6.85 | $15.00 | 118.98% | Buy |
| SMTI | Sanara MedTech | $36.00 | $44.00 | 22.22% | Buy |
| HAE | Haemonetics | $90.75 | $108.25 | 19.28% | Buy |
| NVST | Envista | $20.08 | $23.11 | 15.09% | Hold |
| KRMD | KORU Medical Systems | $3.08 | $3.25 | 5.52% | Buy |
| MMSI | Merit Medical Systems | $101.20 | $100.78 | -0.42% | Buy |
| LMAT | LeMaitre Vascular | $101.52 | $85.25 | -16.03% | Buy |
| ATR | AptarGroup | $174.10 | $138.00 | -20.74% | Buy |